1、 HWANG Y, JEONG H. Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase C alpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1[J]. Br J Pharmacol, 2010, 160(5):1195-1211. HWANG Y, JEONG H. Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase C alpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1[J]. Br J Pharmacol, 2010, 160(5):1195-1211.
2、 XIE W, WANG L, SHENG H, et al. Metformin induces growth inhibition and cell cycle arrest by upregulating microRNA34a in renal cancer cells[J]. Med Sci Monit, 2017(23):29-37. XIE W, WANG L, SHENG H, et al. Metformin induces growth inhibition and cell cycle arrest by upregulating microRNA34a in renal cancer cells[J]. Med Sci Monit, 2017(23):29-37.
3、 WANG X W, HU S, LIANG Q, et al. Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats[J]. Mol Brain, 2012, 5(1):1-7. WANG X W, HU S, LIANG Q, et al. Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats[J]. Mol Brain, 2012, 5(1):1-7.
4、 HSIEH S, TSAI J, YANG S, et al. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression[J]. Amino Acids, 2014, 46(12):2809-2822. HSIEH S, TSAI J, YANG S, et al. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression[J]. Amino Acids, 2014, 46(12):2809-2822.
5、 ARIAANS G, JALVING M, VRIES E, et al. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells[J]. BMC Cancer, 2017, 17(1):232. ARIAANS G, JALVING M, VRIES E, et al. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells[J]. BMC Cancer, 2017, 17(1):232.
6、 GAO Z, LIU Z, BI M, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro[J]. Exp Ther Med, 2016, 11(5):1700-1706. GAO Z, LIU Z, BI M, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro[J]. Exp Ther Med, 2016, 11(5):1700-1706.
7、 SHI Y, HE Z, JIA Z, et al. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo[J]. Mol Med Rep, 2016, 14(4):2921-2928. SHI Y, HE Z, JIA Z, et al. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo[J]. Mol Med Rep, 2016, 14(4):2921-2928.
8、 LUO Q, HU D, HU S, et al. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma[J]. BMC Cancer, 2012, 12(1):517. LUO Q, HU D, HU S, et al. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma[J]. BMC Cancer, 2012, 12(1):517.
9、 JIANG Y, HUANG W, WANG J, et al. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy[J]. Int J Biol Sci, 2014, 10(3):268-277. JIANG Y, HUANG W, WANG J, et al. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy[J]. Int J Biol Sci, 2014, 10(3):268-277.
10、 SHAW R J. Metformin trims fats to restore insulin sensitivity[J]. Nat Med, 2013, 19(12):1570-1572. SHAW R J. Metformin trims fats to restore insulin sensitivity[J]. Nat Med, 2013, 19(12):1570-1572.
